Aneuploidy-induced stress mitigation in iPSCs and differentiated cells
Innovative approach utilizing CRISPR technology to mitigate aneuploidy-induced stress and inflammation in iPSCs and derived cells, potentially reducing pathological effects associated with chromosomal anomalies.